MYOM2 and COVID-19: In contrast, the M protein-specific CD4+ TCLs had a transcriptomic signature of marked suppression of STAT1-IFRs-interferon pathway signaling, a signature that is virtually indistinguishable from the molecular signature seen associated with severe COVID-19.